Clinical trial
Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo…
NCT00133848 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00133848 |
|---|---|
| Title | Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment |
| Official title | A Randomised, Double-blind, Multicentre, Superiority Placebo-controlled, Phase III Study to Assess the Efficacy and Safety of Topical 1% SB-275833 Ointment Versus Placebo Ointment Applied Twice Daily for 5 Days in the Treatment of Adults and Paediatric Subjects With Impetigo. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Impetigo |
| Intervention type | Drug |
| Interventions | SB-275833 ointment, 1% |
| Enrollment | 210 |
| Start date | Apr 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Aug 24, 2005 |
| Last update posted | Sep 23, 2016 |
| Countries | India, Italy, Mexico, Netherlands, Peru |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: